NebidoTM Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
Asset Purch.
- Financing Rounds
-
1
NebidoTM General Information
Description
A testosterone deficiency treatment drug designed for the treatment of hypogonadism in men. The product is used to treat clinical symptoms including regression of secondary sex characteristics, asthenia, decreased libido and erectile dysfunction due to low testosterone levels.
Contact Information
Website
www.nebido.comCorporate Office
- 52078 Aachen
- Germany
Corporate Office
- 52078 Aachen
- Germany
NebidoTM Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
NebidoTM Former Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
NebidoTM FAQs
-
Where is NebidoTM headquartered?
NebidoTM is headquartered in Aachen, Germany.
-
What industry is NebidoTM in?
NebidoTM’s primary industry is Buildings and Property.
-
Is NebidoTM a private or public company?
NebidoTM is a Private company.
-
What is the current valuation of NebidoTM?
The current valuation of NebidoTM is
. -
What is NebidoTM’s current revenue?
The current revenue for NebidoTM is
. -
Who are NebidoTM’s investors?
Bayer has invested in NebidoTM.
-
When was NebidoTM acquired?
NebidoTM was acquired on 02-Nov-2022.
-
Who acquired NebidoTM?
NebidoTM was acquired by Grünenthal.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »